The Physiopathology Behind Valve Degeneration in TAVR

The degeneration of transcatheter biological valves clearly depends on time and starts with thrombus generation and subsequent histological changes resulting in valve failure (due to regurgitation, stenosis, or both).

La enfermedad vascular periférica se asocia a más eventos en el TAVIThrombus formation is the first change, observed early in computerized tomography (CT) scans after implantation. Most times it is completely asymptomatic, which leaves many of us wondering whether we should actually do something about this phenomenon.

 

This study provides more data and tells us that, perhaps, thrombus formation is just the beginning of a series of consecutive events over time such as endothelial hyperplasia, fibrosis, tissue remodeling, proteinase expression, and, ultimately, calcification.

 

This is the first study to investigate processes causing leaflet thickening and structural degeneration of transcatheter valves.


Read also: Bundle Branch Block and Need for Permanent Pacemaker, a Major Challenge after TAVR.


A few alarms went off with the first CT imaging studies showing thrombus formation and thickening. Based on those studies, this work provides histological details to better understand this phenomenon.

 

Researchers studied 23 explanted valves from 22 patients, from 0 to 2583 days after the procedure. Maximal leaflet thickness increased relative to implant duration (p = 0.027). Valves explanted after 2 years were thicker than those with shorter duration (p = 0.0027). All valves had adherent thrombi on both aortic and ventricular sides, which after 60 days combined with fibrosis and after 4 years, with calcification.

 

Early thrombus formation (<60 days after the procedure) occurred despite rapid endothelialization and was associated with an abnormal hyperplastic phenotype. Fibrosis was observed in 6 patients on both the aortic and the ventricular surfaces, and remodeled over time. All these changes were associated with matrix metalloproteinase-1 expression.


Read also: TAVR Is Feasible and Offers Good Outcomes in Patients with Cancer.


Five patients showed calcification, always associated with adherent thrombus and fibrosis.

 

Conclusion

Percutaneous valves degenerate over time. Such process seems to begin with thrombus formation and, after several evolution steps, results in calcification. Future investigations are needed to further understand these phenomena contributing to leaflet thickening and ulterior degeneration, and, above all, to try and prevent it, thus prolonging device duration. So far, the key seems to be taking measures during the earliest stage, the formation of adherent thrombi.

 

Original title: Transcatheter Aortic Heart Valves. Histological Analysis Providing Insight to Leaflet Thickening and Structural Valve Degeneration.

Reference: Stephanie L. Sellers et al. J Am Coll Cardiol Img 2019. Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Su opinión nos interesa. Puede dejar su comentario, reflexión, pregunta o lo que desee aquí abajo. Será más que bienvenido.

More articles by this author

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...